首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 (2S,5S,8S,11S,14S,17S,20S,23S,26S,32S)-32-氨基-11-(3-氨基-3-氧代丙基)-20,23-双(4-氨基丁基)-2,5,8,14,17,26-六(3-((二氨基亚甲基)氨基)丙基)-33-(4-羟基苯基)-4,7,10,13,16,19,22,25,28,31-十氧代-3,6,9,12,15,18,21,24,27,30-十氮杂三十三烷酸

(2S,5S,8S,11S,14S,17S,20S,23S,26S,32S)-32-氨基-11-(3-氨基-3-氧代丙基)-20,23-双(4-氨基丁基)-2,5,8,14,17,26-六(3-((二氨基亚甲基)氨基)丙基)-33-(4-羟基苯基)-4,7,10,13,16,19,22,25,28,31-十氧代-3,6,9,12,15,18,21,24,27,30-十氮杂三十三烷酸

(2S,5S,8S,11S,14S,17S,20S,23S,26S,32S)-32-amino-11-(3-amino-3-oxopropyl)-20,23-bis(4-aminobutyl)-2,5,8,14,17,26-hexakis(3-((diaminomethylene)amino)propyl)-33-(4-hydroxyphenyl)-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazatritriacontanoic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

191936-91-1

中文名称

(2S,5S,8S,11S,14S,17S,20S,23S,26S,32S)-32-氨基-11-(3-氨基-3-氧代丙基)-20,23-双(4-氨基丁基)-2,5,8,14,17,26-六(3-((二氨基亚甲基)氨基)丙基)-33-(4-羟基苯基)-4,7,10,13,16,19,22,25,28,31-十氧代-3,6,9,12,15,18,21,24,27,30-十氮杂三十三烷酸

英文名称

(2S,5S,8S,11S,14S,17S,20S,23S,26S,32S)-32-amino-11-(3-amino-3-oxopropyl)-20,23-bis(4-aminobutyl)-2,5,8,14,17,26-hexakis(3-((diaminomethylene)amino)propyl)-33-(4-hydroxyphenyl)-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazatritriacontanoic acid

别名

HIV-1 TAT PROTEIN (47-57);HIV-1 TAT PROTEIN PEPTIDE;H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-OH;HIV-1 Tat (47-57);HIV-I TAT Protein Peptide;TAT (47-57);TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG;YGRKKRRQRRR

标准英文名

(2S,5S,8S,11S,14S,17S,20S,23S,26S,32S)-32-amino-11-(3-amino-3-oxopropyl)-20,23-bis(4-aminobutyl)-2,5,8,14,17,26-hexakis(3-((diaminomethylene)amino)propyl)-33-(4-hydroxyphenyl)-4,7,10,13,16,19,22,25,28,31-decaoxo-3,6,9,12,15,18,21,24,27,30-decaazatritriacontanoic acid

MDL No.

MFCD07366706

分子式

C64H118N32O14

分子量

1559.86

精确分子量

1558.95

SMILES

NCCCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O

标准SMILES

NC(=O)CC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](N)CC1C=CC(O)=CC=1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O

用途

The TAT peptide (YGRKKRRQRRR) is widely used in gene delivery, drug delivery, and biomedical research due to its highly efficient cell-penetrating ability; it functions as a cell-penetrating peptide (CPP) that can transport conjugated macromolecules—such as DNA, RNA, and therapeutic agents—into cells; it serves as a component in gene therapy vectors to facilitate gene entry into target cells; it enhances intracellular delivery and therapeutic efficacy of drug molecules; it is applied in vaccine development, targeted drug delivery systems, and as a molecular probe for cellular imaging; additionally, TAT can increase the yield and solubility of heterologous proteins.

InChIKey

RAVVEEJGALCVIN-AGVBWZICSA-N

安全信息

SureRoute逆合成路线

1.  191936-91-1 逆合成路线 1

—
—
ACDAII941
191936-91-1
来源: SureRoute

2.  191936-91-1 逆合成路线 2

—
—
ACDAII941
191936-91-1
来源: SureRoute

3.  191936-91-1 逆合成路线 3

—
—
ACDAII941
191936-91-1
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手